Characterization of a novel AB5 cytotoxin
Characterization of a novel AB5 cytotoxin
批准号:
7996641
负责人:
Adrienne W Paton
金额:
$25.7万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-15 至 2011-11-30
关键词:
AffectAnimal ModelAntibodiesApoptosisBacteriaBacterial ToxinsBindingBiologyBioterrorismBloodBlood CellsCategoriesCell DeathCell LineCell surfaceCellsCellular biologyChildCholera ToxinCollaborationsComputer SimulationConfocal MicroscopyCoupledCrystallizationCrystallographyCultured CellsCytosolCytotoxinDataDevelopmentDiseaseDisease OutbreaksDoseElectron MicroscopyEmerging Communicable DiseasesEndoplasmic ReticulumEscherichia coliEukaryotic CellFamilyFluorescence MicroscopyFoundationsFundingFutureGenesGlycolipidsGoalsHarvestHemolytic-Uremic SyndromeHistologicHistopathologyHousingHumanImmunohistochemistryIn VitroInstitutionInvestigationKnock-outKnowledgeLabelLeadLifeMicroscopyModelingMolecularMolecular ChaperonesMusMutateNamesNatureNeurologic ManifestationsOralOrganOutcomePathogenesisPathologyPathway interactionsPertussis ToxinPharmaceutical PreparationsPlasmidsPositioning AttributeProteinsProteomicsPublishingReagentRecombinantsReportingResearchResearch PersonnelResistanceResolutionRoleSerine ProteaseShiga ToxinSpecificityStressStructureTargeted ToxinsTestingTherapeuticTherapeutic AgentsTimeTissuesToxic effectToxinVero CellsVirulence FactorsWestern BlottingX-Ray Crystallographybasebiodefensecell injurycellular targetingcytotoxiccytotoxicitydesigngastrointestinalgastrointestinal infectiongene cloningglycolipid receptorholotoxinshuman diseasein vivoinsightlaboratory facilitymouse modelmutantnovelpathogenprogramsreceptorresponseretrograde transportsmall moleculetherapeutic vaccinethree dimensional structuretissue tropismtooltraffickinguptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We have recently discovered a novel "Subtilase cytotoxin" produced by a strain of Shiga toxigenic
Escherichia coli (a category B Priority Pathogen) that was responsible for an outbreak of hemolytic uremic
syndrome (HUS). It belongs to a new class of AB5 cytotoxins, because its A subunit has distinct enzymic
activity and it has no sequence similarity with any of the other AB5 toxin families (cholera, Shiga and
pertussis toxins). Subtilase cytotoxin is extraordinarily cytotoxic for cultured cells and is lethal for mice (with
histopathology similar to that of HUS). Apart from its possible role in severe human disease, it is a potential
bioterrorism agent which could have global impact. The long-term objective of this response to PA-04-119
is complete structural and functional characterization of the emerging toxin. Its Specific Aims are:
1. Elucidation of the molecular basis for cytotoxicity.
A subunit Subtilase-like serine protease activity is essential for cytotoxicity, and preliminary data indicate that
the ER chaperone BiP is a key cellular target for the toxin. In this Aim, we will continue our investigation of
the molecular basis for cytotoxicity by examining the downstream consequences of BiP cleavage, including
whether this results in ER stress and apoptosis.
2. Investigation of toxin trafficking in target cells.
We hypothesize that after binding to the cell surface, the toxin must undergo retrograde transport to the ER
in order to exert its toxic effects. Intracellular toxin trafficking will therefore be examined by co-localization of
labelled toxin with cellular compartmental markers using confocal microscopy.
3. Examination of tissue tropism and in vivo effects of the toxin.
The distribution of toxin receptors in mouse tissues and trafficking of labelled toxin in vivo will be examined
using fluorescence, confocal and electron microscopy. The direct contribution of Subtilase cytotoxin to the
pathogenesis of STEC disease will also be investigated in a mouse model.
4. Determination of the 3Dstructure of the toxin.
X-ray crystallography and computer modelling will be used to solve the 3D structure.
Relevance: This project will provide essential information on the basic biology of this emerging toxin,
particularly its structure and the mechanism whereby it damages cells and tissues. This will provide a
foundation for the future development of countermeasures including therapeutic agents and vaccines.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1038/nature07428
发表时间:
2008-12-04
期刊:
NATURE
影响因子:
64.8
作者:
[Byres, Emma, Paton, Adrienne W., Paton, James C., Lofling, Jonas C., Smith, David F., Wilce, Matthew C. J., Talbot, Ursula M., Chong, Damien C., Yu, Hai, Huang, Shengshu, Chen, Xi, Varki, Nissi M., Varki, Ajit, Rossjohn, Jamie, Beddoe, Travis]
通讯作者:
Beddoe, Travis
DOI:
10.1016/j.tibs.2010.02.003
发表时间:
2010-07
期刊:
TRENDS IN BIOCHEMICAL SCIENCES
影响因子:
13.8
作者:
[Beddoe, Travis, Paton, Adrienne W., Le Nours, Jerome, Rossjohn, Jamie, Paton, James C.]
通讯作者:
Paton, James C.
DOI:
10.3390/toxins2020215
发表时间:
2010-02-01
期刊:
Toxins
影响因子:
4.2
作者:
[Paton AW, Paton JC]
通讯作者:
Paton JC
DOI:
10.4049/jimmunol.0900017
发表时间:
2009-07-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, Ogata R, Huang T, Nakajima S, Yao J, Paton AW, Paton JC, Kitamura M]
通讯作者:
Kitamura M
Tissue factor–dependent procoagulant activity of subtilase cytotoxin, a potent AB5 toxin produced by shiga toxigenic Escherichia coli.
枯草杆菌酶细胞毒素的组织因子依赖性促凝血活性,枯草杆菌酶细胞毒素是由产志贺毒素大肠杆菌产生的强效 AB5 毒素。
DOI:
10.1086/656534
发表时间:
2010
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
[Wang,Hui, Paton,JamesC, Thorpe,ChelesteM, Bonder,ClaudineS, Sun,WaiYan, Paton,AdrienneW]
通讯作者:
Paton,AdrienneW
共 6 条
Characterization of a novel AB5 cytotoxin
-
批准号:7544533
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2006
-
负责人:Adrienne W Paton
-
依托单位:
Characterization of a novel AB5 cytotoxin
-
批准号:7327767
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2006
-
负责人:Adrienne W Paton
-
依托单位:
Characterization of a novel AB5 cytotoxin
-
批准号:7193025
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2006
-
负责人:Adrienne W Paton
-
依托单位:
Characterization of a novel AB5 cytotoxin
-
批准号:7740212
-
项目类别:
-
资助金额:$26.22万
-
财政年份:2006
-
负责人:Adrienne W Paton
-
依托单位:
海外基金